You are not logged in!
Do you want to login? It's free!
Who do you implu? Create a Free Account!
Attachment 1
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported):
June 9, 2008
PHARMA
BIO- SERV, INC.
(Exact
name of registrant as specified in its charter)
|
Delaware
|
0-50956
|
20-0653570
|
|
|
(State
or other jurisdiction
|
(Commission
|
(IRS
Employer
|
|
|
of
Incorporation)
|
File
Number)
|
Identification
No.)
|
|
|
Pharma-Bio
Serv Building
Industrial
Zone Lot 14,
Barrio
Higuillar, Dorado, Puerto Rico
|
00646
|
||
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant’s
telephone number, including area code:
(787) 278-2709
NONE
(Former
name or former address, if changed since last report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the Registrant under any of the following
provisions:
¨ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
¨ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Effective
as of June 9, 2008, Pharma-Bio Serv, Inc. (the "Company") extended the
employment agreement dated January 2, 2008 between the Company and Elizabeth
Plaza, its Chief Executive Officer, for an additional year to expire on January
1, 2010. All other terms and conditions of Ms. Plaza's employment agreement
remain the same.
Effective
as of June 16, 2008, the Company eliminated the Chief Operating Officer
position, as part of a board meeting decision to refocus its operations
initiatives and reduce operating costs.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
PHARMA-BIO
SERV, INC.
|
|
|
Date:
June 20, 2008
|
By:
/s/ Elizabeth
Plaza
|
|
Elizabeth
Plaza, Chief Executive Officer
|